Some clinics also use lower-dose continuous protocols (1 to 2 mg daily) on the theory that steady-state exposure might produce better effects than cycling
Community protocols describe a 50 mg/day starting phase lasting 1-2 weeks, escalating to 100-150 mg/day based on tolerance
Published preclinical work often looks at cell migration, blood-vessel signalling, fibroblast activity, epithelial barrier models, and how local tissue environments respond under controlled conditions
Drug Interactions: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays
Correct use: Run a 10-day Epithalon cycle, then take 4 months off, then begin the next protocol
SB431542 (ALK5 block) for TGF-1-SMAD-dependent osteoblast/fibroblast differentiation endpoints distinct from Nrf2